Granules India Limited

533.9

INR
+1.50(+0.28%)
As of November 14, 2024 10:00:00 AM

Granules India Limited Share Price Information

24 hour Low and High

Low: 527.5
High: 544

All time High

718.10

Price Change 1h

+₹-3.95 +-0.73%

Price Change 1d

+₹-3.95 +-0.73%

Price Change 1w

+₹-38.20 +-6.68%

Granules India Limited Market Information

Exchange

NSE

Market Cap

13446.63 Cr

About Granules India Limited Share

Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India and internationlly. The company's APIs in various therapeutic categories include anti-retrovirals, anti-hypertensives, anti-histamines, anti-infectives, analgesics, anti-coagulants, anti-fibriotics, and platelet inhibitors. It also offers tablets, caplets, and press-fit capsules in bulk, blister packs, and bottles; high potent products; and other products for oncology. Granules India Limited was founded in 1984 and is based in Hyderabad, India.

Sector

Healthcare

Drug Manufacturers - Specialty & Generic

Employees

about

4057

CEO

Dr. Kandiraju Venkata Sita Ram Rao B.Tech, M.E., Ph.D.

Revenue (2023)

%

Country of Origin

India

Key Highlights

  • Stock market today: Aarti Industries, Granules, Hindustan Copper among five stocks in F&O ban list on November 12 | Stock Market News
  • Granules India's Stock Sees -5.05% Decline, MarketsMOJO Gives 'Hold' Call
  • Trade Spotlight: How should you trade Bharti Hexacom, HCL Technologies, Granules India, Dr Lal PathLabs,...
  • Stocks Under F&O Ban: Manappuram Finance, Granules India, and Others
  • Is Weakness In Granules India Limited (NSE:GRANULES) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

FAQs

Granules India Limited

533.9

INR
+1.50(+0.28%)
As of November 14, 2024 10:00:00 AM

Granules India Limited Share Price Information

24 hour Low and High

Low: 527.5
High: 544

All time High

718.10

Price Change 1h

+₹-3.95 +-0.73%

Price Change 1d

+₹-3.95 +-0.73%

Price Change 1w

+₹-38.20 +-6.68%

Granules India Limited Market Information

Exchange

NSE

Market Cap

13446.63 Cr

About Granules India Limited Share

Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India and internationlly. The company's APIs in various therapeutic categories include anti-retrovirals, anti-hypertensives, anti-histamines, anti-infectives, analgesics, anti-coagulants, anti-fibriotics, and platelet inhibitors. It also offers tablets, caplets, and press-fit capsules in bulk, blister packs, and bottles; high potent products; and other products for oncology. Granules India Limited was founded in 1984 and is based in Hyderabad, India.

Sector

Healthcare

Drug Manufacturers - Specialty & Generic

Employees

about

4057

CEO

Dr. Kandiraju Venkata Sita Ram Rao B.Tech, M.E., Ph.D.

Revenue (2023)

%

Country of Origin

India

Key Highlights

  • Stock market today: Aarti Industries, Granules, Hindustan Copper among five stocks in F&O ban list on November 12 | Stock Market News
  • Granules India's Stock Sees -5.05% Decline, MarketsMOJO Gives 'Hold' Call
  • Trade Spotlight: How should you trade Bharti Hexacom, HCL Technologies, Granules India, Dr Lal PathLabs,...
  • Stocks Under F&O Ban: Manappuram Finance, Granules India, and Others
  • Is Weakness In Granules India Limited (NSE:GRANULES) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

FAQs